Key findings: STEP 1 (68 weeks, 2.4 mg Wegovy, n=1,961): 44% of participants reported nausea, with the majority resolving it within the dose-escalation phase
That means that a big open question is whether the side effect profiles may differ in subgroups of people that scientists have not directly studied, which include a large swath of people now taking these drugs to lose only about 10 to 15 pounds
R.BerkM
Low-impact activities such as swimming, walking, or yoga may be better tolerated than high-impact exercise during the adjustment period
Protein-forward meals, water, and GLP-1 supplement support, plus lower-fat foods during escalation, all help with tolerance
Progression of nodular malignant melanoma to metastatic amelanotic melanoma in 3 years: an unusual event